{UAH} Fwd: Portrait of an HIV Conspirator
View this email in your browser: http://www.the-scientist.com/TheScientist/emails/cultureFriday/2013/09/13a.html | September 13, 2013 | |||||||
| ||||||||
| ||||||||
Selected StoriesCovering the life sciences inside and out | ||||||||
Portrait of an HIV ConspiratorBy Ed Yong The three-dimensional structure of CCR5, a protein which HIV uses to infect humans cells, could lead to better anti-HIV drugs. | ||||||||
A New Way of SeeingBy M. Joan Dawson Inspiration and controversy attended the birth of magnetic resonance imaging, a diagnostic technology that changed the course of human medicine. | ||||||||
Capsule ReviewsBy Bob Grant Rocket Girl, The Cancer Chronicles, Abominable Science!, and The Sports Gene | ||||||||
The NutshellDaily News Roundup | ||||||||
Week in Review: September 9–13By Tracy Vence
A new type of stem cell; a parasitic ant species protects its hosts; reasons for biodiversity among tropical amphibians; transforming translational research
| ||||||||
SIV Vaccine SuccessBy Kate Yandell A cytomegalovirus-based vaccine eliminated simian immunodeficiency virus from rhesus macaques, raising hopes of a similarly effective HIV vaccine. | ||||||||
Golden Goose Awards Given AgainBy Erin Weeks Researchers behind high-impact studies that at first seemed obscure are honored in another round of prizes. | ||||||||
MultimediaVideo, Slideshows, Infographics | ||||||||
Image of the Day
Scanning electron micrograph of a bedbug's (Cimex lectularius) compound eye | ||||||||
Going Viral
Bacteriophages shuttle genes between diverse ecosystems. | ||||||||
Sponsored WebinarsEducational videos and online seminars | ||||||||
Focus on Stem Cell Research
In this free webinar, our panel of experts will share their perspectives on the pros and cons of using induced pluripotent stem cells (iPSCs) for research. | ||||||||
| ||||||||
| ||||||||
Home News & Opinion The Nutshell Multimedia Magazine Advertise About/Contact Privacy Policy Job Listings Subscribe Archive Copyright © 2013 LabX Media Group All rights reserved. Terms of Use. |
0 comments:
Post a Comment